Long-Term Follow Up and Treatment Outcomes of A 2 Year-Old-Boy With Metastatic Testosterone-Secreting Adrenocortical Carcinoma

ABSTRACT: Objective: Treatment of metastatic adrenocortical carcinoma (ACC) is challenging and long-term survival rates are exceedingly low. Long-term outcome data for pediatric patients who received mitotane is very limited. Methods: We describe the case of a 2-year-old boy with ACC with a lung me...

Full description

Bibliographic Details
Main Authors: Danielle LoGiurato, MD, Zoltan Antal, MD, Ping Zhou, MD
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520306398